Loss of fibroblast HIF-1α accelerates tumorigenesis

J Kim, C Evans, A Weidemann, N Takeda, YS Lee… - Cancer research, 2012 - AACR
J Kim, C Evans, A Weidemann, N Takeda, YS Lee, C Stockmann, C Branco-Price
Cancer research, 2012AACR
Solid tumors consist of malignant cells and associated stromal components, including
fibroblastic cells that contribute to tumor growth and progression. Although tumor fibrosis
and aberrant vascularization contribute to the hypoxia often found in advanced tumors, the
contribution of hypoxic signaling within tumor-associated fibroblasts to tumorigenesis
remains unknown. In this study, we used a fibroblast-specific promoter to create mice in
which key hypoxia regulatory genes, including VHL, HIF-1α, HIF-2α, and VEGF-A, were …
Abstract
Solid tumors consist of malignant cells and associated stromal components, including fibroblastic cells that contribute to tumor growth and progression. Although tumor fibrosis and aberrant vascularization contribute to the hypoxia often found in advanced tumors, the contribution of hypoxic signaling within tumor-associated fibroblasts to tumorigenesis remains unknown. In this study, we used a fibroblast-specific promoter to create mice in which key hypoxia regulatory genes, including VHL, HIF-1α, HIF-2α, and VEGF-A, were knocked out specifically in tumor stromal fibroblasts. We found that loss of HIF-1α and its target gene VEGF-A accelerated tumor growth in murine model of mammary cancer. HIF-1α and VEGF-A loss also led to a reduction in vascular density and myeloid cell infiltration, which correlated with improved tumor perfusion. Together, our findings indicate that the fibroblast HIF-1α response is a critical component of tumor vascularization. Cancer Res; 72(13); 3187–95. ©2012 AACR.
AACR